Michael S Brown Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

Michael S Brown is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 1,382 shares of REGN, which is worth approximately $1.59 Million. The most recent transaction as insider was on Jun 25, 2021, when has been sold 2,084 shares (Common Stock) at a price of $549.0 per share, resulting in proceeds of $1,144,116. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.38K

0% 3M change

10.83% 12M change

Total Value Held $1.59 Million

MICHAEL S BROWN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 25 2021	SELL Open market or private sale	$1,144,116 $549.0 p/Share	2,084 Reduced 70.05%	891 Common Stock
Jun 25 2021	BUY Exercise of conversion of derivative security	$773,998 $371.4 p/Share	2,084 Added 41.19%	2,975 Common Stock
Jun 14 2021	SELL Open market or private sale	$892,500 $525.0 p/Share	1,700 Reduced 65.61%	891 Common Stock
Jun 14 2021	BUY Exercise of conversion of derivative security	$631,380 $371.4 p/Share	1,700 Added 39.62%	2,591 Common Stock
Jan 25 2021	SELL Open market or private sale	$1,374,714 $554.32 p/Share	2,480 Reduced 73.57%	891 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$944,756 $380.95 p/Share	2,480 Added 42.39%	3,371 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	248 Added 21.77%	891 Common Stock

MSB

Michael S Brown

Director

Tarrytown, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Value

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN

Account